Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Alexander

Showing results (201-210 of 314) with videos related to

Pageof 32
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|February 18, 2020
All-cause mortality, stroke, and bleeding in patients with atrial fibrillation and valvular heart diseaseJarl Emanuel Strange, Caroline Sindet-Pedersen, Laila Staerk, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 25, 2020
Differential risk factor profile of diabetes and atherosclerosis in rural, sub-urban and urban regions of South India: The KMCH-Non-communicable disease studiesGanesan Velmurugan, Sundaresan Mohanraj, Mani Dhivakar, et al.
Journal of Clinical Lipidology|January 30, 2026
VLDL cholesterol and ASCVD risk: A population-based studyMie Balling, Otto Grøn Roepstorff, Thomas Alexander Gerds, et al.
Pathogens (Basel, Switzerland)|October 27, 2022
Nitric Oxide Production and Effects in Group B <i>Streptococcus</i> ChorioamnionitisMary Frances Keith, Kathyayini Parlakoti Gopalakrishna, Venkata Hemanjani Bhavana, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 27, 2018
Safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism: a nationwide studyCaroline Sindet-Pedersen, Laila Staerk, Jannik Langtved Pallisgaard, et al.
American Journal of Therapeutics|May 21, 2025
Continued Versus Interrupted Oral Anticoagulation During Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation: A Meta-AnalysisHritvik Jain, Nandan Patel, Muhammad Daoud Tariq, et al.
BMJ (Clinical Research Ed.)|April 15, 2024
Predicting the risks of kidney failure and death in adults with moderate to severe chronic kidney disease: multinational, longitudinal, population based, cohort studyPing Liu, Simon Sawhney, Uffe Heide-Jørgensen, et al.
Current Problems in Cardiology|May 20, 2023
Prevalence and Prognostic Implications of Amyloidosis in Valvular Heart DiseaseBilal Hussain, Sanchit Duhan, Ahmed Mahmood, et al.
Open Heart|January 13, 2023
Development and validation of prediction models for incident atrial fibrillation in heart failureNicklas Vinter, Thomas Alexander Gerds, Pia Cordsen, et al.
Gynecologic Oncology|May 14, 2026
Adding HE4 to the IOTA ADNEX model for differentiating adnexal masses: A Danish prospective, multicenter studyNikoline Schou Karlsen, Claus Kim Høgdall, Eva Dreisler, et al.
Pageof 32

Showing results (201-210 of 314) with videos related to

Sort By:
Pageof 32
European Heart Journal. Cardiovascular Pharmacotherapy|February 18, 2020
All-cause mortality, stroke, and bleeding in patients with atrial fibrillation and valvular heart diseaseJarl Emanuel Strange, Caroline Sindet-Pedersen, Laila Staerk, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 25, 2020
Differential risk factor profile of diabetes and atherosclerosis in rural, sub-urban and urban regions of South India: The KMCH-Non-communicable disease studiesGanesan Velmurugan, Sundaresan Mohanraj, Mani Dhivakar, et al.
Journal of Clinical Lipidology|January 30, 2026
VLDL cholesterol and ASCVD risk: A population-based studyMie Balling, Otto Grøn Roepstorff, Thomas Alexander Gerds, et al.
Pathogens (Basel, Switzerland)|October 27, 2022
Nitric Oxide Production and Effects in Group B <i>Streptococcus</i> ChorioamnionitisMary Frances Keith, Kathyayini Parlakoti Gopalakrishna, Venkata Hemanjani Bhavana, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 27, 2018
Safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism: a nationwide studyCaroline Sindet-Pedersen, Laila Staerk, Jannik Langtved Pallisgaard, et al.
American Journal of Therapeutics|May 21, 2025
Continued Versus Interrupted Oral Anticoagulation During Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation: A Meta-AnalysisHritvik Jain, Nandan Patel, Muhammad Daoud Tariq, et al.
BMJ (Clinical Research Ed.)|April 15, 2024
Predicting the risks of kidney failure and death in adults with moderate to severe chronic kidney disease: multinational, longitudinal, population based, cohort studyPing Liu, Simon Sawhney, Uffe Heide-Jørgensen, et al.
Current Problems in Cardiology|May 20, 2023
Prevalence and Prognostic Implications of Amyloidosis in Valvular Heart DiseaseBilal Hussain, Sanchit Duhan, Ahmed Mahmood, et al.
Open Heart|January 13, 2023
Development and validation of prediction models for incident atrial fibrillation in heart failureNicklas Vinter, Thomas Alexander Gerds, Pia Cordsen, et al.
Gynecologic Oncology|May 14, 2026
Adding HE4 to the IOTA ADNEX model for differentiating adnexal masses: A Danish prospective, multicenter studyNikoline Schou Karlsen, Claus Kim Høgdall, Eva Dreisler, et al.
Pageof 32